Skip to main content
. 2022 Oct 4;207(4):475–484. doi: 10.1164/rccm.202203-0597OC

Table 2.

Baseline Characteristics of Subjects with Asthma by Tertile of Paraspinous Muscle Density

  Male
Female
  First Tertile
(>48 HU)
Second Tertile (42–48 HU) Third Tertile (<42 HU)   First Tertile
(>46.4 HU)
Second Tertile (38.2–46.4 HU) Third Tertile (<38.2 HU)  
Characteristic (n = 24) (n = 25) (n = 24) P Value (n = 48) (n = 49) (n = 49) P Value
Age at baseline, yr* 42.0 ± 13.7 43.6 ± 16.1 54.3 ± 10.2 0.005 41.0 ± 12.3 48.5 ± 13.5 52.8 ± 12.9 <0.001
Body mass index, kg/m2* 27.6 ± 4.8 29.4 ± 5.2 36.1 ± 6.9 <0.001 29.9 ± 7.8 32.2 ± 8.0 39.0 ± 10.3 <0.001
Body surface area, m2* 2.04 ± 0.18 2.07 ± 0.23 2.26 ± 0.25 0.002 1.86 ± 0.23 1.90 ± 0.24 2.02 ± 0.26 0.005
Asthma duration, yr* 29.6 ± 17.0 29.9 ± 13.7 29.3 ± 18.4 0.99 23.7 ± 12.9 28.1 ± 13.7 29.6 ± 15.2 0.10
Baseline exacerbations in prior 6 mo 0 (0–2) 1 (0–3) 0 (0–1) 0.66 1 (0–3) 1 (0–3) 1 (0–3) 0.79
Severe asthma 13 (54.2) 20 (80.0) 20 (83.3) 0.05 27 (56.3) 33 (67.3) 35 (71.4) 0.27
Number of controller medications 2 (1–3) 2 (2–3) 3 (2–4) 0.03 3 (2–3) 2 (2–3) 3 (2–3) 0.66
Maintenance oral corticosteroid use 1 (4.2) 4 (16.0) 7 (29.2) 0.07 5 (10.4) 10 (20.4) 7 (14.3) 0.38
ACT score* 17.0 ± 5.4 16.6 ± 4.2 14.9 ± 5.6 0.31 17.0 ± 4.8 17.2 ± 4.9 15.5 ± 5.3 0.21
Pre-BD FEV1% predicted* 66.7 ± 21.9 66.2 ± 18.4 63.7 ± 16.5 0.84 80.0 ± 20.0 77.119.9 70.9 ± 18.8 0.07
CT airway volume, mm3* 11,666 ± 2,867 10,521 ± 2,767 9,737 ± 2,560 0.06 9,000 ± 3,096 9,085 ± 2,292 7,452 ± 2,652 0.004
CT airway volume, BSA adjusted, mm3*§ 1,087 ± 2,836 −80 ± 2,682 −1,003 ± 2,542 0.03 540 ± 3,092 595 ± 2,277 −1,124 ± 2,637 0.002

Definition of abbreviations: ACT = Asthma Control Test; BD = bronchodilator; BSA = body surface area; CT = computed tomography; HU = Hounsfield units; PSMD = paraspinous muscle density.

*

Distribution for continuous measures is mean ± SD.

Distribution for ordinal measures is median (interquartile range).

Distribution for categorical measures is n (%)

§

BSA-adjusted airway volume represents the value above or below the expected airway volume for BSA (residual from a linear model).